Related Experiment Video

Updated: Jan 27, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

Molecular docking studies of angiogenesis target protein HIF-1α and genistein in breast cancer

Vidya Mukund1, Madhu Sudhana Saddala2, Batoul Farran3

  • 1Department of Bioscience and Biotechnology, Banasthali University, Banasthali RAJ-304022, India.

Gene
|April 2, 2019
PubMed

Insights

Genistein was found to reduce hypoxia-inducible factor-1α (HIF-1α) in breast cancer cells. This suggests genistein could be a potential therapeutic agent for breast cancer by targeting HIF-1α.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hypoxia-inducible factor-1α (HIF-1α) is a key regulator in various diseases, including breast cancer (BC).
  • Therapeutic strategies targeting HIF-1α present a promising avenue for cancer management.
  • Genistein, a soy isoflavone, exhibits anti-malignant properties, but its precise mechanism in BC remains unclear.

Purpose of the Study:

  • To investigate the effect of genistein on HIF-1α expression in breast cancer cell lines.
  • To elucidate the molecular interactions between genistein and HIF-1α using molecular docking.

Main Methods:

  • Breast cancer cell lines were treated with genistein.
  • HIF-1α expression levels were assessed.
  • Molecular docking simulations were performed to analyze genistein's binding site on HIF-1α.

Main Results:

  • Genistein significantly downregulates HIF-1α expression in breast cancer cells.
  • Molecular docking revealed that genistein binds to the FIH-1 binding site of the HIF-1α protein.

Conclusions:

  • Genistein exhibits a novel mechanism of action in breast cancer by downregulating HIF-1α.
  • Genistein, or other HIF-1α antagonists, may represent a potential therapeutic strategy for breast cancer treatment.
Keywords:
Breast cancerDockingGenisteinHIF-1α

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.2K
Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound12:23

Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound

Published on: August 14, 2012

14.9K

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
19.7K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

14.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.5K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K